Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, B-Cell 2Recurrence 1Pancreatic Neoplasms 1Liver Neoplasms 1Hematologic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 26fludarabine 18Dexamethasone 17pembrolizumab 12Rituximab 11Etoposide 10venetoclax 9pomalidomide 9Gemcitabine 9fludarabine phosphate 7daratumumab 7Lenalidomide 7Bortezomib 7carfilzomib 6obinutuzumab 5glofitamab 5Vincristine 5Temozolomide 5Prednisone 5Nivolumab 5Immunotherapy, Adoptive 5Cisplatin 5Calcium Dobesilate 5selinexor 4cemiplimab 4Doxorubicin 4Cytarabine 4Carboplatin 4zanubrutinib 3ruxolitinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Cell- and Tissue-Based Therapy × 90 days × Clear all
NCT06158139 2026-03-19

Autologous CAR-T Cells Targeting B7-H3 in PDAC

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
27 enrolled
Gastrointestinal

Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡